Rev Esp Quimioter 2017; 30 (Suppl. 1): 26-29
|Comments on practice guidelines for the diagnosis and management of aspergillosis made by the IDSA in 2016
ELVIRA ALARCÓN-MANOJA, CELIA CARDOZO-ESPINOLA, PEDRO PUERTA-ALCALDE, CAROLINA GARCÍA-VIDAL
We sought to review the most important updates in the treatment of aspergillosis after the publication of the clinical practice guidelines for the diagnosis and management of invasive aspergillosis (IA) by the Infectious Diseases Society of America. Our aim is to discuss some of the key aspects concerning the following topics: early initiation of antifungal therapy, antifungal agent of choice, follow-up of patients with IA, and breakthrough aspergillosis.
Rev Esp Quimioter 2017; 30 (Suppl. 1): 26-29 [pdf]